Shareholders' Equity (Details) - USD ($)		3 Months Ended		12 Months Ended
	Jun. 27, 2025	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Shareholders’ Equity [Abstract]
Number of shares issued (in Shares)		1,733
Stock-based compensation expense		$ 90,134
Share Repurchase Program, Authorized, Amount		$ 26,000,000
Stock repurchased during period (in Shares)		3,521
Amount paid to repurchase shares during the year		$ 195,773	$ 96,024
Amount of common stock repurchased		$ 21,035,328
Number of common stock acquired (in Shares)		1,402,790
Weighted-average grant date fair value, options granted		$ 18.32
Exercisable at ending balance (in Shares)		0
Fair value of options granted		$ 1,763,747
Stock options, vesting period		5 years
Unrecognized compensation expense of stock options		$ 1,557,977
Weighted-average period of stock options		4 years 5 months 1 day
Stock Options [Member]
Shareholders’ Equity [Abstract]
Stock-based compensation expense		$ 88,187	$ 0
Expected dividend yield		0.00%		0.00%
Stock Option Plan 2025 [Member]
Shareholders’ Equity [Abstract]
Number of shares reserved for issuance (in Shares)	300,000
Number of shares granted (in Shares)		96,250
Number of shares remained for future issuance (in Shares)		203,750
Options exercised (in Shares)		0
Termination term of stock option plan		10 years
Exercise price for stock options as a percentage of fair market value		100.00%
Stock Option Plan 2025 [Member] | Maximum [Member]
Shareholders’ Equity [Abstract]
Exercise period of options		10 years
Stock Option Plan 2025 [Member] | Minimum [Member]
Shareholders’ Equity [Abstract]
Exercise price for stock options as a percentage of fair market value		110.00%
Ownership percentage by employee		10.00%